Clin2
NCT06298838Possibly a fitNot yet recruiting

Imaging during prostate cancer surgery to remove cancer more completely

Prostate Cancer

Part of Cancer, Kidney & urinary clinical trials.

This study tests a special imaging technique (called PSMA PET-CT) that may help doctors see prostate cancer more clearly during surgery. It could help them remove the cancer more completely, and it might give you a more targeted treatment.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
10 people
Ages
18 years to 80 years
Study type
Observational

Who can take part

  • You are a man age 18 or older.
  • You have been diagnosed with high-risk prostate cancer.
  • Your doctor has already told you that you need surgery to remove your prostate and nearby lymph nodes.
  • You are willing and able to follow the study plan.
  • You have no active viral or fungal infections.
  • You have not had radiation therapy to your prostate before.
  • You have not been in another study with radiation exposure in the past year.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06398613Recruiting
Using PSMA PET scan before prostate cancer surgery

This trial is testing whether a special scan (PSMA PET/CT) before surgery can help doctors decide if you need to remove lymph nodes. It is for men with high-risk prostate cancer who are already planning to have robot-assisted prostate removal.

Oslo
NCT06122584Recruiting· Phase 3
PSMA PET scan for high-risk prostate cancer before surgery

This trial tests if a special PET scan using PSMA-1007 can find prostate cancer spread in men who have just been diagnosed with high-risk prostate cancer and plan to have surgery. The scan may help doctors better understand the cancer before removing the prostate and lymph nodes.

Nancy
NCT05520255Recruiting· Phase 3
PSMA PET/CT scan to guide care after prostate cancer treatment

This Phase 3 study checks whether a PSMA PET/CT scan (using a special tracer) can help doctors make better decisions for people with prostate cancer after treatment, based on PSA blood test changes. It may help identify whether cancer has spread or how to plan next steps.

Edmonton, Alberta
NCT06565247Recruiting· Phase 3
Comparing PET and MRI scans before prostate cancer surgery

This trial tests if a special PET scan (PSMA-PET) plus MRI is better than MRI alone at finding the full extent of high-risk prostate cancer before surgery. It aims to improve surgical planning by checking scan results against the removed prostate tissue.

Malmö
NCT05000827Recruiting
PSMA PET scan to guide lymph node surgery in prostatectomy

This study tests whether a special prostate scan called PSMA PET/CT can help doctors decide which pelvic lymph nodes to remove during prostate surgery. It may improve who needs lymph node surgery by using scan results to guide the operation.

Nijmegen, Gelderland
NCT06003556Recruiting· Phase 2
PSMA-guided ablation for prostate cancer

This trial tests a targeted treatment for prostate cancer using PSMA imaging to guide ablation (removal) of the tumor. It may help men with early-stage, localized cancer that hasn't spread.

Calgary, Alberta

Hear when a new Prostate cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.